Table of Content


1. Executive Summary


2. Japan In–Vitro Diagnostics (IVD) Market and Market Share Analysis – Forecast to 2030

2.1 Japan IVD Market and Forecast (2008 – 2030)
2.2 By Segment – Japan IVD Market Share and Forecast (2008 – 2030)
2.3 By Company – Japan IVD Share and Forecast (2015 – 2030)


3. Japan IVD – Segments Wise Market and Forecast (2008 – 2030)

3.1 Urine & Feces Market and Forecast
3.2 Hematology Market and Forecast
3.3 Clinical Chemistry Market and Forecast
3.4 SMBG Market and Forecast
3.5 Tumor Marker Market and Forecast
3.6 Immunoassay Market and Forecast
3.7 Infectious Disease Market and Forecast
3.8 Microbiology Market and Forecast
3.9 Pathology Market and Forecast
3.10 Genetic Testing Market and Forecast
3.11 Others Market and Forecast


4. Japan IVD Market – Company Analysis (2014 – 2030)

4.1 Roche Diagnostics

4.1.1 Company Overview
4.1.2 Roche Diagnostics – Japan IVD Sales and Forecast
4.1.3 Recent Developments

4.2 Abbott Laboratories

4.2.1 Company Overview
4.2.2 Abbott Laboratories – Japan IVD Sales and Forecast
4.2.3 Recent Developments

4.3 Danaher Corporation

4.3.1 Company Overview
4.3.2 Danaher Corporation – Japan IVD Sales and Forecast
4.3.3 Recent Developments

4.4 bioM?rieux S.A.

4.4.1 Company Overview
4.4.2 Biomerieux – Japan IVD Sales and Forecast
4.4.3 Recent Developments

4.5 Sysmex Corporation

4.5.1 Company Overview
4.5.2 Sysmex Corporation – Japan IVD Sales and Forecast
4.5.3 Recent Developments

4.6 Bio–Rad Laboratories, Inc.

4.6.1 Company Overview
4.6.2 Bio–Rad Laboratories, Inc – Japan IVD Sales and Forecast
4.6.3 Recent Developments

4.7 Becton Dickinson and Company

4.7.1 Company Overview
4.7.2 Becton Dickinson and Company – Japan IVD Sales and Forecast
4.7.3 Recent Developments

4.8 Thermo Fisher Scientific Inc.

4.8.1 Company Overview
4.8.2 Thermo Fisher Scientific Inc. – Japan IVD Sales and Forecast
4.8.3 Recent Developments

4.9 Others – Japan IVD Sales and Forecast


5. In-Vitro Diagnostics (IVD) Market – Major Deals


6. In-Vitro Diagnostics (IVD) Market - Recent Developments


7. Japan In–Vitro Diagnostics – Market Dynamics

7.1 Japan IVD Market – Driving Factors
7.2 Japan IVD Market – Challenges



List of Figures


List of Figures:

Figure 2-1: Japan – IVD Market (Million US$), 2008 – 2023
Figure 2-2: Japan – Forecast for IVD Market (Million US$), 2024 – 2030

Figure 3-1: Japan – Urine & Feces Market (Million US$), 2008 – 2023
Figure 3-2: Japan – Forecast for Urine & Feces Market (Million US$), 2024 – 2030
Figure 3-3: Japan – Hematology Market (Million US$), 2008 – 2023
Figure 3-4: Japan – Forecast for Hematology Market (Million US$), 2024 – 2030
Figure 3-5: Japan – Clinical Chemistry Market (Million US$), 2008 – 2023
Figure 3-6: Japan – Forecast for Clinical Chemistry Market (Million US$), 2024 – 2030
Figure 3-7: Japan – SMBG Market (Million US$), 2008 – 2023
Figure 3-8: Japan – Forecast for SMBG Market (Million US$), 2024 – 2030
Figure 3-9: Japan – Tumor Marker Market (Million US$), 2008 – 2023
Figure 3-10: Japan – Forecast for Tumor Marker Market (Million US$), 2024 – 2030
Figure 3-11: Japan – Immunoassay Market (Million US$), 2008 – 2023
Figure 3-12: Japan – Forecast for Immunoassay Market (Million US$), 2024 – 2030
Figure 3-13: Japan – Infectious Disease Market (Million US$), 2008 – 2023
Figure 3-14: Japan – Forecast for Infectious disease Market (Million US$), 2024 – 2030
Figure 3-15: Japan – Microbiology Market (Million US$), 2008 – 2023
Figure 3-16: Japan – Forecast for Microbiology Market (Million US$), 2024 – 2030
Figure 3-17: Japan – Pathology Market (Million US$), 2008 – 2023
Figure 3-18: Japan – Forecast for Pathology Market (Million US$), 2024 – 2030
Figure 3-19: Japan – Genetic Testing Market (Million US$), 2008 – 2023
Figure 3-20: Japan – Forecast for Genetic Testing Market (Million US$), 2024 – 2030
Figure 3-21: Japan – Others Market (Million US$), 2008 – 2023
Figure 3-22: Japan – Forecast for Others Market (Million US$), 2024 – 2030

Figure 4-1: Roche Diagnostics – Japan IVD Sales (Million US$), 2012 – 2023
Figure 4-2: Roche Diagnostics – Forecast for Japan IVD Sales (Million US$), 2024 – 2030
Figure 4-3: Abbott Laboratories – Japan IVD Sales (Million US$), 2012 – 2023
Figure 4-4: Abbott Laboratories – Forecast for Japan IVD Sales (Million US$), 2024 – 2030
Figure 4-5: Danaher Corporation – Japan IVD Sales (Million US$), 2014 – 2023
Figure 4-6: Danaher Corporation – Forecast for Japan IVD Sales (Million US$), 2024 – 2030
Figure 4-7: biomerieux – Japan IVD Sales (Million US$), 2015 – 2023
Figure 4-8: Biomerieux – Forecast for Japan IVD Sales (Million US$), 2024 – 2030
Figure 4-9: Sysmex Corporation – Japan IVD Sales (Million US$), 2010 – 2023
Figure 4-10: Sysmex Corporation – Forecast for Japan IVD Sales (Million US$), 2024 – 2030
Figure 4-11: Bio–Rad Laboratories, Inc – Japan IVD Sales (Million US$), 2014 – 2023
Figure 4-12: Bio–Rad Laboratories, Inc – Forecast for Japan IVD Sales (Million US$), 2024 – 2030
Figure 4-13: Becton Dickinson and Company – Japan IVD Sales (Million US$), 2014 – 2023
Figure 4-14: Becton Dickinson and Company – Forecast for Japan IVD Sales (Million US$), 2024 – 2030
Figure 4-15: Thermo Fisher Scientific Inc. – Japan IVD Sales (Million US$), 2014 – 2023
Figure 4-16: Thermo Fisher Scientific Inc. – Forecast for Japan IVD Sales (Million US$), 2024 – 2030
Figure 4-17: Others – Japan IVD Sales (Million US$), 2015 – 2023
Figure 4-18: Others – Forecast for Japan IVD Sales (Million US$), 2024 – 2030

List of Tables


List of Tables:

Table 2-1: By Segment – Japan IVD Market Share (Percent), 2008 – 2023
Table 2-2: By Segment – Forecast for Japan IVD Market Share (Percent), 2024 – 2030
Table 2-3: By Company – Japan IVD Market Share (Percent), 2015 – 2023
Table 2-4: By Company – Forecast for Japan IVD Market Share (Percent), 2024 – 2030